Model-Based Meta-Analysis (MBMA) Archives

Publication

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…

Certara2025年11月5日

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025年10月31日

Guide

MBMA vs. Meta-Analysis: Quick Comparison Guide

Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…

Certara2025年10月8日

Blog

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

GSK shares real-world case studies on how Model-Based Meta-Analysis (MBMA) supports dose selection, virtual control…

Certara2025年7月31日

Blog

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

2025年6月30日 Drug development is increasingly defined by its complexity. Teams must navigate rising…

Certara2025年6月30日

On-Demand Webinar

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…

Certara2025年6月18日

Publication

A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition

The serotonin reuptake transporter (SERT) is responsible for the removal and recycling of the neurotransmitter…

Certara2025年4月30日

On-Demand Webinar

相対的治療効果および絶対的アウトカムに関するモデルに基づくメタ解析（MBMA）：概念と応用

Vice President, MBMA Capability Lead, Certara Drug Development Solutions Matt advances the integration of published…

Certara2025年4月10日

On-Demand Webinar

医薬品開発の全段階でモデルに基づくメタ解析（MBMA）を適用：公開済み臨床アウトカムの活用方法［アジア向けウェビナー］

Vice President, Quantitative Science Services, Certara Matt advances the integration of published clinical outcomes data…

Certara2025年4月3日

Publication

The Unrealized Potential of Advanced Modeling Methods to Inform Early Strategic Planning for Payer Reimbursement

This article explores the overlooked yet critical role of early strategic planning for payer reimbursement…

Certara2025年2月25日

Powered by Translations.com GlobalLink Web Software

モデルに基づくメタ解析（MBMA）

Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

MBMA vs. Meta-Analysis: Quick Comparison Guide

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

A translational model-based meta-analysis to predict tremor incidence associated with serotonin reuptake transporter inhibition

相対的治療効果および絶対的アウトカムに関するモデルに基づくメタ解析（MBMA）：概念と応用

医薬品開発の全段階でモデルに基づくメタ解析（MBMA）を適用：公開済み臨床アウトカムの活用方法［アジア向けウェビナー］

The Unrealized Potential of Advanced Modeling Methods to Inform Early Strategic Planning for Payer Reimbursement

メルマガ登録

クイックアクセス

ソリューション

お問合せ